Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Citigroup Trims Target on Tradeweb Despite Record Trading Activity

Andreas Sommer by Andreas Sommer
September 9, 2025
in Analysis, Banking & Insurance, Trading & Momentum
0
Tradeweb Markets Stock
0
SHARES
189
VIEWS
Share on FacebookShare on Twitter

While Tradeweb Markets Inc. continues to post impressive trading volumes, Citigroup has opted to tighten its expectations. The financial giant has maintained its ‘Buy’ recommendation but made a significant downward revision to its price target, sending a mixed message to investors.

The adjustment, announced yesterday, sees the price objective lowered to $150 from $170, an 11.76% reduction. This decision by Citigroup’s analysts follows the release of Tradeweb’s operational metrics for August, which highlighted robust activity across its electronic trading platforms.

Strong Volumes Underscore Operational Strength

Tradeweb’s latest metrics reveal a business performing well. The company reported a total trading volume of $54.1 trillion for August. This equated to an average daily volume (ADV) of $2.5 trillion, marking a solid 11.3% increase compared to the same period last year.

Growth was particularly vigorous in several key product areas:
* Repurchase agreements (Repo): ADV surged 16.6% to $750.4 billion
* European government bonds: ADV climbed 20.4%, reaching $44.3 billion
* Interest rate derivatives: Total ADV expanded by 20.8% to $878.5 billion
* European credit products: ADV rose 23.8% to $1.8 billion

Should investors sell immediately? Or is it worth buying Tradeweb Markets?

The sole underperformer was U.S. government debt, which saw a 3.9% decline in activity. This dip was attributed primarily to softer volume from both institutional and retail client segments.

Investor Focus Shifts to Upcoming Conference

Market attention now turns to the Barclays Global Financial Services Conference, where Tradeweb is scheduled to present today. These events often provide management with a platform to offer further context on recent performance and detail their strategic roadmap for the future.

The critical question for the market is whether this presentation can counterbalance the cautious tone from Citigroup. The overall analyst consensus for Tradeweb remains favorable, carrying a “Moderate Buy” rating. The average price target among analysts sits at $151.93.

The next major catalyst for the stock will arrive on October 30, when the company is slated to report its full financial results for the third quarter of 2025. Currently, Tradeweb shares are trading near $119, a level that remains substantially below most analyst projections despite the recent target cut.

Ad

Tradeweb Markets Stock: Buy or Sell?! New Tradeweb Markets Analysis from February 7 delivers the answer:

The latest Tradeweb Markets figures speak for themselves: Urgent action needed for Tradeweb Markets investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Tradeweb Markets: Buy or sell? Read more here...

Tags: Tradeweb Markets
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Allscripts Healthcare Stock
Analysis

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Next Post
AbbVie Stock

Three Strategic Moves Position AbbVie for Future Growth

Markel Stock

Strategic Refinement Drives Markel's Path Forward

Ecopetrol Stock

Strategic Shift for Ecopetrol Following Venezuela Sanctions

Recommended

Abbott Laboratories Stock

Can Abbott’s AI Innovation and Dividend Track Record Propel Its Shares?

3 weeks ago

Empowering the Next Generation enCore Energys Education Society and Scholarship Programs

2 years ago
Synopsys Stock

Synopsys Shares Face Critical Test Amid Legal and Analyst Concerns

2 months ago
Technology Blockchain Trading online

Applied Digital Corporation Announces Disappointing Financial Performance and Decline in Stock Price

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

Yirendai Charts a New Course with Tech-Driven Strategy

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Trending

Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

by Rodolfo Hanigan
February 7, 2026
0

Shares of HBT Financial have recently climbed to a new 52-week peak of $29.37, propelled by a...

Allscripts Healthcare Stock

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Avanos Medical Stock

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • HBT Financial Stock Surges as Strategic Acquisition Nears Completion
  • Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth
  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com